摘要
目的通过对HBVDNA单一反应性献血者的追踪检测,为建立HBVDNA单一反应性献血者屏蔽和归队策略提供依据及数据支持。方法对HBVDNA单一反应性献血者屏3个月后追踪采样,然后进行HBsAg双试剂ELISA及HBVDNA检测,对HBsAg及HBVDNA均无反应性献血者继续追踪两次。结果第一次追踪到HBVDNA单一反应性献血者36人,所有标本HBsAg双试剂均无反应性,HBVDNA无反应性17人,HBVDNA反应性19人。对17人HBVDNA无反应性的献血者继续进行第2次追踪,其中HBVDNA为无反应性15人,对该无反应性15人进行第3次追踪,全部无反应性。结论让经2次HBVDNA追踪检测均为无反应性的HBVDNA单一反应性献血者归队的归队策略是可行的。
Objective To provide evidence and data support for the establishment of screening and returning strategies for HBVDNA single reactive blood donors by tracking and testing HBVDNA single reactive blood donors. Methods HBV DNA single reactive blood donors screens were sampled after 3 months, then double reagent ELISA and HBV DNA were detected. HBsAg and HBV DNA non reactive blood donors were followed up twice. Results Thirty-six HBVDNA single reactive blood donors were tracked for the first time. No HBsAg double reagents were found in all samples, 17 HBVDNA non-reactive and 19 HBVDNA reactive. Seventeen unresponsive donors of HBVDNA were followed up for the second time, including 15 unresponsive donors and 15 unresponsive donors. Conclusion It is feasible to bring the single reactive blood donors back after two HBVDNA tracing tests.
作者
袁文声
林惠燕
吴泳伦
YUAN Wen-sheng;LIN Hui-yan;WU Yong-lun(Zhongshan Central Blood Station,Zhongshan 528400,China)
出处
《中国医药指南》
2019年第13期93-94,共2页
Guide of China Medicine
